Grünenthal links up with forest to develop two analgesics
This article was originally published in Scrip
Executive Summary
Grünenthal of Germany has signed a license agreement with the Irish subsidiary of Forest Laboratories to co-develop and commercialise its new oral small-molecule analgesics GRT 6005 and GRT 6006.